RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
Chinese pharmaceutical group WuXi AppTec has said it is lobbying hard in Washington against a proposed bill that threatens its business in the US, where it generates 65 per cent of its revenues.
WuXi AppTec is a major supplier of essential ingredients to many of the largest global pharmaceutical companies and conducts drug development for them.
Its sister company WuXi Biologics, conducts research and develops drugs for pharmaceutical groups.
https://www.ft.com/content/e6358d2a-2d2c-4f80-80b7-864e2d754fd4